IX International symposium. Focus on primary angle-closure glaucoma (PACG)

About symposium

The Russian Ophthalmologist Society, Russian Academy of Sciences, Burnasyan Federal Medical Biophysical Center, Nongovernmental Ecological Organization “GREENLIGHT,” and the Russian Society of Cataract and Refractive Surgeons (RSCRS) are happy to invite you to participate in the IX International Symposium “Controversies in Glaucoma: Focus on Primary Angle-Closure Glaucoma (PACG)” on November 6, 2020.

Every year, symposium “Controversies in Glaucoma” catches the interest of ophthalmologists all over the globe and attracts many participants. The symposium has been expanding and attracting more and more contributors, which has become possible through telebridges with ophthalmologists from other countries. The goal of the symposium is to expand and broaden the expertise of Russian medics in the field of glaucoma diagnostics and treatment, as well as to establish a dialog between Russian and foreign specialists on the most complicated and controversial aspects of glaucoma.

This year’s symposium will be marked by the participation of international experts from the United Kingdom (P. Foster, A. Azuara-Blanco, G. Gazzard), Hong Kong (C. Tham), and China (S. Zhang). The project is authored and coordinated by Professor Natalya Kurysheva. The telebridge will be moderated by Professor Natalya Kurysheva, Professor Boris Maluygin, and Professor Vladimir Trubilin.

Download the program (PDF)

Reports

Natalia I. Kurysheva

Russia

Opening of the symposium and presentation of speakers

The introduction and greetings

Paul Foster

the United Kingdom

PACG: Epidemiology, prevalence and anatomical risk factors. Do we need to change the classification?

The report provides the definition of the primary angle closure of the anterior chamber and considers natural course of the pathology associated with the development of the primary angle closure (PAC) and primary angle-closure glaucoma (PACG). It presents the results of the population-based studies on the disease prevalence among different age and ethnic groups, describes the anatomical risk factors for the PAC development, including the role of socioeconomic status and various medicines in the pathology development. The report considers genetic syndromes associated with PAC and recent advances in molecular genetics.

Xiulan Zhang

China

What are the mechanisms of angle closure? Do we consider all of them in the clinical practice?

The report discusses new clinical parameters reflecting the features of the anatomical structures of the eye in case of PAC, obtained with OCT. Particular attention is paid to the role of the choroid and the pathogenesis of plateau iris syndrome. The report considers the role of OCT of the anterior and posterior segment of the eye in determining the treatment strategy in PAC and PACG.

Natalia I. Kurysheva

Russia

The special features of optic neuropathy and its progression in PACG. What is the role of local medical treatment and SLT?

The report presents clinical study data describing the difference in changes in the optic nerve head, microcirculation and visual fields, as well as the PACG progression rate compared with POAG. It demonstrates the speaker’s own studies data on OCT angiography in PACG, considers the selection of drug treatment choice for PACG in case of insufficient IOP compensation after laser iridotomy (LI), as well as the role of selective laser trabeculoplasty after LI in patients with PACG as compared with POAG.

Augusto Azuarа-Blanco

the United Kingdom

What is a role of LPI and the clear lens extraction in angle- closure glaucoma?

The report examines the results of the EAGLE study and provides the rationale for the treatment strategy choice in PAC and PACG. It demonstrates that replacing a clear lens is more effective for IOP reduction than LI, and is more economically justified in the long term.

Clement Tham

Hong Kong, China

Surgical options for Primary Angle Closure Glaucoma (PACG)

The report provides a classification of various PAC PACG conditions, based on which it is advisable to choose a particular treatment strategy, depending on the features of the anterior chamber angle, the disease stage and the IOP level. It considers modern methods of PACG surgical treatment, including goniosinechiolysis, micropulse and endoscopic cyclophotocoagulation, as well as combined techniques.

Gus Gazzard

the United Kingdom

How can we personalize the PACG treatment?

The report discusses the factors influencing the treatment choice in PAC and PACG. It considers in detail the main conditions for laser peripheral iridotomy and clear lens extraction, depending on age, refraction and stage of the disease. The results of the ZAP and EAGLE study are analyzed. The report examines the place of sinus trabeculectomy in the PACG general treatment.

Natalia I. Kurysheva

Russia

Discussion

Natalia I. Kurysheva

Russia

Discussion

Reporter

Gus Gazzard

the United Kingdom

S.H. Ho prof. of Ophthalmology & Visual Sciences and Chairman of Department of Ophthalmology and Visual Sciences at the Chinese University of Hong Kong, Director of the CUHK Eye Centre, Honorary Chief-of-Service of the Hong Kong Eye Hospital, Deputy Director of the Shantou University/The Chinese University of Hong Kong Joint Shantou International Eye Centre, Honorary Consultant of the New Territories East Cluster Ophthalmology Service, Vice President and Fellowship Examiner at the College of Ophthalmologists of Hong Kong (COHK), Secretary General &CEO of the Asia-Pacific Academy of Ophthalmology (APAO), Vice President of the Asia-Pacific Glaucoma Society (APGS), Chair of the Academia Ophthalmologica Internationalis (AOI), member of the Board of Governors of the World Glaucoma Association. Research interests: primary angle closure glaucoma – laser and surgical treatments, pattern and risk factors for disease progression, genetics, mechanism of angle closure, intraocular pressure fluctuations. Principal Investigator of the three multicentre randomized controlled surgical trials on the outcomes of cataract and clear lens extraction in PACG. Was awarded the inaugural Nakajima Award by the APAO and the Ten Outstanding Young Persons Award in 2005 for his work on prevention of blindness; received the APAO Outstanding Service in Prevention of Blindness Award in 2011, the APAO Distinguished Service Award in 2013 and the Senior Achievement Award from the American Academy of Ophthalmology (AAO) in 2016; presented the Holmes Award Lecture, the highest award for prevention of blindness in the Asia-Pacific region, at the 28th APAO Congress in 2013; presented the APAO De Ocampo Award Lecture at the APAO 2015 Congress, the highest award for excellent academic achievements in eye research.

Clement Tham

Hong Kong, China

S.H. Ho Professor of Ophthalmology Visual Sciences and Chairman of Department of Ophthalmology and Visual Sciences at the Chinese University of Hong Kong, Director of the CUHK Eye Centre, Honorary Chief-of-Service of the Hong Kong Eye Hospital, Deputy Director of the Shantou University/The Chinese University of Hong Kong Joint Shantou International Eye Centre, Honorary Consultant of the New Territories East Cluster Ophthalmology Service, Vice President and Fellowship Examiner at the College of Ophthalmologists of Hong Kong (COHK), Secretary General &CEO of the Asia-Pacific Academy of Ophthalmology (APAO), Vice President of the Asia-Pacific Glaucoma Society (APGS), Chair of the Academia Ophthalmologica Internationalis (AOI), member of the Board of Governors of the World Glaucoma Association. Research interests: primary angle closure glaucoma – laser and surgical treatments, pattern and risk factors for disease progression, genetics, mechanism of angle closure, intraocular pressure fluctuations. Principal Investigator of the three multicentre randomized controlled surgical trials on the outcomes of cataract and clear lens extraction in PACG. Was awarded the inaugural Nakajima Award by the APAO and the Ten Outstanding Young Persons Award in 2005 for his work on prevention of blindness; received the APAO Outstanding Service in Prevention of Blindness Award in 2011, the APAO Distinguished Service Award in 2013 and the Senior Achievement Award from the American Academy of Ophthalmology (AAO) in 2016; presented the Holmes Award Lecture, the highest award for prevention of blindness in the Asia-Pacific region, at the 28th APAO Congress in 2013; presented the APAO De Ocampo Award Lecture at the APAO 2015 Congress, the highest award for excellent academic achievements in eye research.

Paul Foster

the United Kingdom

prof., Consultant Ophthalmic Surgeon of MooRussiaields Private Eye Hospital, Council member of the International Society of Ophthalmic Epidemiology, member of the Advisory Board of the World Glaucoma Association, fellow of the Royal College of Surgeons of Edinburgh, fellow of the Royal College of Ophthalmologists (London), fellow of the Royal College of Surgeons of England, member of the NICE Glaucoma Guidelines Committee, member of the Executive Committee, prof. of Glaucoma Studies and Theme Leader – Integrative Epidemiology &Visual Function of the UCL Institute of Ophthalmology. Research interests: epidemiology, genetics and clinical management of angle-closure glaucoma; lifestyle, environment and diet and glaucoma; prevention of angle-closure glaucoma by laser surgery. The author of more than 135 scientific papers and 18 book chapters on eye disease. Member of the Editorial Board of Journal of Glaucoma, British Medical Bulletin, Ophthalmic Epidemiology, Current Eye Research, Asian Journal of Ophthalmology. Recipient of the Claffy medal of the University of New South Wales (2012), Ron Lowe Medal of the Australian and New Zealand Glaucoma Society (2007), MooRussiaields Eye Hospital research gold medal (2002); elected member of the Glaucoma Research Society (2002); listed in the Ophthalmologist Top 100 Power List 2016.

Xiulan Zhang

China

<ul><li>Professor of Ophthalmology at Zhongshan Ophthalmic Center (ZOC) ,China</li><li>TOP 100 most influential people in ophthalmology in the Ophthalmologist Power List (2023, 2014)</li><li>TOP 100 most influential people in ophthalmology in the Asia-Pacific region (2023)</li><li>Top 50 Expertise in Glaucoma Worldwide in Expertscape (2020-2023)</li><li>Fellow of the Academy of Asia-Pacific Professor of Ophthalmology (AAPPO)</li><li>Board member of the Asia-Pacific Glaucoma Society (APGS), the Asia-Pacific Ocular Imaging Society (APOIS) and International AI in Ophthalmology Society (IAIOph)</li><li>Convener of the Glaucoma Scientific Program of Asia-Pacific Academy of Ophthalmology (APAO 2024 , 2019 and2018)</li><li>The Distinguished Service Award of APAO 2021, the Achievement Award of APAO in 2017 </li><li>The Prestigious Achievement Award of Ophthalmic Image Analysis in 2019</li><li>Published 185 SCI articles, Cite Index 5860（Google), H Index 44 (Google Scholar)</li><li>Published four self-authored books<ul class="sub"><li>Illustrated Surgical Techniques and Pearls of MIGS (2022)</li><li>Illustrated anterior segment examinations and diagnosis of glaucoma(2020)</li><li>Illustrated surgical techniques and pearls of glaucoma(2016)</li><li>Illustrated clinical diagnosis and treatment of glaucoma(2014)</li></ul></li><li>Published ten books of translated versions of The WGA Consensus Series and The Asia-Pacific Glaucoma Guideline</ul>

Natalia I. Kurysheva

Russia

Head of the Department of Eye Diseases of the Federal Medical and Biological University of Innovations and Continuing Education of the FMBA of Russia; Professor of the Department of Ophthalmology of the APO of the FSBI FNCC of the FMBA of Russia; Head of the Consultative and Diagnostic Department of the Center of Ophthalmology of the FMBA of Russia; a member of the European Glaucoma Society and the American Academy of Ophthalmology; honorary member of the Italian Glaucoma Society; scientific supervisor and coordinator of the Federal Target Group Programs «Glaucoma Opticoneuropathy». Natalia is a representative of Russian Ophthalmology in the European Association of Predictive, Preventive and Personalized Medicine. The research interests: etiology, pathogenesis, laser and surgical treatment of glaucoma, neuroprotection, angle-closure, normotensive and pseudoexfoliative glaucoma, retinal diseases. For the last 10 years, she has been studying new methods of optic nerve and retina visualization in glaucoma, the progression of the disease, and ocular blood flow and the personalized treatment of the primary angle clouser. Author of more than 300 scientific papers, including 50 papers in international peer-reviewed journals, 10 monographs on the diagnosis and treatment of glaucoma and ocular blood flow, as well as 10 patents for inventions. Member of the editorial board of the National Journal of Glaucoma (Russia) and Ophthalmology Journal (Russia), a reviewer of the British Journal of Ophthalmology (BJO), Bulletin of Ophthalmology and other prominent international journals. She was awarded by the Ministry of Education of the Russian Federation for scientific research on topical issues of fundamental and applied science in the field of education, achievements in the training of highly qualified specialists, for the introduction of new forms and methods of teaching in the educational process. The author of two recent monographs: COVID-19 and visual organ damage, 2021, and Dry age-related macular degenerations, 2021, a member of International Optical Circulation Society (IOCS).

Augusto Azuarа-Blanco

the United Kingdom

Clinical prof. at the Centre for Public Health in the School of Medicine, Dentistry and Biomedical Sciences of Queen’s University Belfast, member of the Executive Committee of the European Glaucoma Society (2016-2020), Lead of the European Glaucoma Society Guidelines Committee, member of the 2017 NICE glaucoma guidelines, ex-president of the UK & Eire Glaucoma Society. Research interests: development of new technologies for eye diseases treatment, including innovative diagnostic tests. Chief coordinator of several international trials, such as EAGLE (a multicentre RCT comparing primary lens extraction versus laser iridotomy in patients with angle-closure glaucoma) and GATE (a UK-based multicentre diagnostic study evaluating automated imaging technologies in glaucoma), as well as a number of UK-based studies on glaucoma (TAGS and GLAURIOUS), diabetic retinopathy (DIAMONDS and EMERALD) and age-related macular degeneration (EDNA and MIRROR). The author of over 210 peer-reviewed papers, over 20 book chapters, and edited three books. Works have been cited over 5000 times and current Scopus h-index is 40. Member of the Editorial Board of several specialist journals, including the Cochrane Eye and Vision Group, EYE and Journal of Glaucoma. Examiner for the Royal College of Surgeons of Edinburgh. Recipient of the 2008 American Academy of Ophthalmology achievement award; honorary member of the Italian Glaucoma Society; King James IV prof.ship by the Royal College of Surgeons of Edinburgh (2019).

Program

November 6, 2020

12:00 – 12:05

Welcoming speech and introductions

prof. Kurysheva N., Russia

12:00 – 12:05

12:05 – 12:25

PACG: epidemiology, prevalence and anatomical risk factors. do we need to change the classification?

prof. Foster P., the United Kingdom

12:05 – 12:25

12:25 – 12:45

What are the mechanisms of angle closure? do we consider all of them in the clinical practice?

prof. Zhang X., China

12:25 – 12:45

12:45 – 13:00

The special features of optic neuropathy and its progression in PACG. what is the role of local medical treatment and slt?

prof. Kurysheva N., Russia

12:45 – 13:00

13:00 – 13:20

Discussion

prof. Kurysheva N., Russia

13:00 – 13:20

13:20 - 13:40

What is a role of lpi and the clear lens extraction in angle-closure glaucoma?

prof. Azuarа-Blanco A., the United Kingdom

13:20 - 13:40

13:40 – 14:00

Surgical options for primary angle closure glaucoma (PACG).

prof. Tham K., Hong Kong, China

13:40 – 14:00

14:00 – 14:20

How can we personalize the pacg treatment?

prof. Gazzard G., the United Kingdom

14:00 – 14:20

14:20 – 14:45

Discussion

prof. Kurysheva N., Russia

14:20 – 14:45

IX International symposium
Focus on primary angle-closure glaucoma (PACG)

About symposium

Reports

Reporter

Program

Welcoming speech and introductions

PACG: epidemiology, prevalence and anatomical risk factors. do we need to change the classification?

What are the mechanisms of angle closure? do we consider all of them in the clinical practice?

The special features of optic neuropathy and its progression in PACG. what is the role of local medical treatment and slt?

Discussion

What is a role of lpi and the clear lens extraction in angle-closure glaucoma?

Surgical options for primary angle closure glaucoma (PACG).

How can we personalize the pacg treatment?

Discussion

Organizers

Sponsors

Partners

Information partners